vimarsana.com

Page 6 - ஊக்குவிக்கவும் மருத்துவ அமைப்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AirEye Raises $8M Series A to Extend Network Security into the Unprotected Digital Airspace

AirEye Raises $8M Series A to Extend Network Security into the Unprotected Digital Airspace USA - English News provided by Share this article Share this article TEL-AVIV, Israel, April 22, 2021 /PRNewswire/ AirEye, the Network Airspace Protection (NAP) leader, announced today that it raised $8 million in a Series A funding round led by U.S. Venture Partners (USVP). Steve Krausz, General Partner at USVP, joined the company s Board of Directors. Canaan Partners also participated in the round. AirEye addresses the largest unprotected and hence vulnerable network environment - the digital corporate airspace, said Shlomo Touboul, CEO and co-founder of AirEye. The company has been doing extensive research into the vulnerabilities and attacks and has coined the term of Antenna for Hire

Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG) and Abbott Labs (NYSE: ABT)

Markets Intuitive Surgical (ISRG) Leerink Partners analyst Richard Newitter maintained a Hold rating on Intuitive Surgical today and set a price target of $860.00. The company’s shares closed last Tuesday at $811.11, close to its 52-week high of $826.81. According to TipRanks.com, Newitter is a 5-star analyst with an average return of 27.9% and a 71.4% success rate. Newitter covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Zimmer Biomet Holdings, and Organogenesis Holdings. Intuitive Surgical has an analyst consensus of Moderate Buy, with a price target consensus of $881.38, implying a 9.3% upside from current levels. In a report released today, Oppenheimer also upgraded the stock to Hold.

Inspire Medical Systems, Inc Announces FDA Approval of Two-Incision Implant ProcedureTwo-incision approach reduces average procedure time by approximately 20 percent

Inspire Medical Systems, Inc Announces FDA Approval of Two-Incision Implant ProcedureTwo-incision approach reduces average procedure time by approximately 20 percent
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

Is Inspire Medical Systems (INSP) Stock a Buy For 2021?

Is Inspire Medical Systems (INSP) Stock a Buy For 2021? Wasatch Ultra Growth Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 23.2% for the quarter, underperforming its benchmark, the Russell 2,000 Growth Index which returned 29.6% in the same quarter. You should check out Wasatch’s top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021. In the Q4 2020 Investor Letter, Wasatch highlighted a few stocks and Inspire Medical Systems Inc. (NYSE:INSP) is one of them. Inspire Medical Systems Inc. (NYSE:INSP) operates as a medical technology company. In the last three months, Inspire Medical Systems Inc. (NYSE:INSP) stock gained 26.1% and on February 25th it had a closing price of $226.24. Here is what Wasatch said:

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.